COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?

Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26.COV2.S, and two mRNA-based vaccines, BNT162b2 and mRNA.1273, have been approved by the European Medicines Agency (EMA), and are invaluable in preventing and reducing the incidence of coronavirus disease-2019 (COVID-19). Recent reports have poin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundstrom, Kenneth, Barh, Debmalya, Uhal, Bruce D., Takayama, Kazuo, Aljabali, Alaa A. A., Abd El-Aziz, Tarek Mohamed, Lal, Amos, Redwan, Elrashdy M., Adadi, Parise, Chauhan, Gaurav, Sherchan, Samendra P., Azad, Gajendra Kumar, Rezaei, Nima, Serrano-Aroca, Ángel, Bazan, Nicolas G., Hassan, Sk Sarif, Panda, Pritam Kumar, Pal Choudhury, Pabitra, Pizzol, Damiano, Kandimalla, Ramesh, Baetas-da-Cruz, Wagner, Mishra, Yogendra Kumar, Palu, Giorgio, Brufsky, Adam M., Tambuwala, Murtaza M., Uversky, Vladimir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301964/
https://www.ncbi.nlm.nih.gov/pubmed/34356644
http://dx.doi.org/10.3390/biom11071020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301964/
https://www.ncbi.nlm.nih.gov/pubmed/34356644
http://dx.doi.org/10.3390/biom11071020

Ejemplares similares